Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
מצבים רפואיים
PDAC · PDAC - Pancreatic Ductal Adenocarcinoma · NSCLC · RAS Mutation · MTAP Deletion · Lung Cancer · Pancreatic Cancer Metastatic · Thoracic Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
Contact: Principal Investigator (Mitesh Borad, MD)Sarah Cannon Research Institute Denver, Denver, Colorado, United States
Contact: Principal Investigator (Gerald Falchook, MD, MS)Georgetown University Medical Center, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Marcus Noel, MD)Mayo Clinic Jacksonville, Jacksonville, Florida, United States
Contact: Principal Investigator (Hani Babiker, MD)Northwestern Memorial Hospital, Chicago, Illinois, United States
Contact: Principal Investigator (Chengwei Peng, MD)University of Indiana, Indianapolis, Indiana, United States
Contact: Principal Investigator (Anita Turk, MD)University of Iowa Health Care, Iowa City, Iowa, United States
Contact: Principal Investigator (Naomi Fei, MD, MS)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Harshabad Singh, MD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Kimberly Perez, MD)Mayo Clinic Cancer Center, Rochester, Minnesota, United States
Contact: Principal Investigator (Kaushal Parikh, MD)Nebraska Cancer Specialists, Omaha, Nebraska, United States
Contact: Principal Investigator (Joel Michalski, MD, PhD)NYU Langone Health, New York, New York, United States
Contact: Principal Investigator (Kristen Spencer, DO, MPH)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Eileen O'Reilly, MD)University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Contact: Principal Investigator (Shetal Patel, MD, PhD)University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Jordi Rodon Ahnert, MD)NEXT Dallas, Irving, Texas, United States
Contact: Principal Investigator (Siraj Sen, MD)Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Vaia Florou, MD, MS)NEXT Oncology, Fairfax, Virginia, United States
Contact: Principal Investigator (Alexander Spira, MD, PhD)
מובילי המחקר
Maxim Pimpkin, MD, PhD
Study Director
Tango Therapeutics, Inc.